Spinal RhoA/Rho kinase signalling pathway may participate in the development of bone cancer pain

Basic and Clinical Pharmacology and Toxicology

Volumn 113, Issue 2, 2013, Pages 87-91

  Hang, Li Hua ^a   Shao, Dong Hua ^a   Chen, Zheng ^a   Sun, Wen Jin ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; EXOENZYME C3; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROCK2 PROTEIN; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CANCER; CANCER CELL CULTURE; CANCER PAIN; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; TIBIA;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BONE NEOPLASMS; ENZYME INHIBITORS; FEMALE; INJECTIONS, SPINAL; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SPINAL CORD; UP-REGULATION;

RATTUS;

EID: 84880309558     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12069     Document Type: Article

References (34)

1. Flemming K. The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. J Pain Symptom Manage 2010;39:139-54.
2. Holzer P, Ahmedzai SH, Niederle N, Leyendecker P, Hopp M, Bosse B et al. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J Opioid Manag 2009;5:145-51.
3. Delaney A, Fleetwood-Walker SM, Colvin LA, Fallon M. Translational medicine: cancer pain mechanisms and management. Br J Anaesth 2008;101:87-94.
4. Middlemiss T, Laird BJ, Fallon MT. Mechanisms of cancer-induced bone pain. Clin Oncol (R Coll Radiol) 2011;23:387-92.
5. Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW. Bone cancer pain. Ann N Y Acad Sci 2010;1198:173-81.
6. Gold MS, Gebhart GF. Nociceptor sensitization in pain pathogenesis. Nat Med 2010;16:1248-57.
7. Rajalu M, Müller UC, Caley A, Harvey RJ, Poisbeau P. Plasticity of synaptic inhibition in mouse spinal cord lamina II neurons during early postnatal development and after inactivation of the glycine receptor alpha3 subunit gene. Eur J Neurosci 2009;30:2284-92.
8. Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL. Mechanism of cancer pain. Mol Interv 2010;10:164-78.
9. Mantyh PW, Hunt SP. Mechanisms that generate and maintain bone cancer pain. Novartis Found Symp 2004;260:221-38.
10. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420:629-35.
11. Hannan JL, Albersen M, Kutlu O, Gratzke C, Stief CG, Burnett AL et al. Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury. J Urol 2013;189:1155-61.
12. Loirand G, Guérin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 2006;98:322-34.
13. Wang HG, Lu FM, Jin I, Udo H, Kandel ER, de Vente J et al. Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins. Neuron 2005;45:389-403.
14. Nakayama AY, Harms MB, Luo L. Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J Neurosci 2000;20:5329-38.
15. Wei H, Pertovaara A. Regulation of neuropathic hypersensitivity by α(2) -adrenoceptors in the pontine A7 cell group. Basic Clin Pharmacol Toxicol 2013;112:90-5.
16. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004;10:712-8.
17. Tatsumi S, Mabuchi T, Katano T, Matsumura S, Abe T, Hidaka H et al. Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS). Neuroscience 2005;131:491-8.
18. Ohsawa M, Aasato M, Hayashi SS, Kamei J. RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice. Pain 2011;152:114-22.
19. Chan FK, Chung SS, Ng IO, Chung SK. The RhoA GTPase-activating protein DLC2 modulates RhoA activity and hyperalgesia to noxious thermal and inflammatory stimuli. Neurosignals 2012;20:112-26.
20. Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000;98:585-98.
21. Li T, Fang Y, Yang G, Zhu Y, Xu J, Liu L. The mechanism by which RhoA regulates vascular reactivity after hemorrhagic shock in rats. Am J Physiol Heart Circ Physiol 2010;299:H292-9.
22. Lan LS, Ping YJ, Na WL, Miao J, Cheng QQ, Ni MZ et al. Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol Pain 2010;6:2.
23. Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF et al. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun 2006;345:1292-8.
24. Hang LH, Yang JP, Yin W, Wang LN, Guo F, Ji FH et al. Activation of spinal TDAG8 and its downstream PKA signaling pathway contribute to bone cancer pain in rats. Eur J Neurosci 2012;36:2107-17.
25. Hu JH, Yang JP, Liu L, Li CF, Wang LN, Ji FH et al. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord. Brain Res 2012;1465:1-9.
26. Kerdsan W, Thanoi S, Nudmamud-Thanoi S. Changes in the neuronal glutamate transporter EAAT3 in rat brain after exposure to methamphetamine. Basic Clin Pharmacol Toxicol 2012;111:275-8.
27. Slatkin N. Cancer-related pain and its pharmacologic management in the patient with bone metastasis. J Support Oncol 2006;4:15-21.
28. Theriault RL. Biology of bone metastases. Cancer Control 2012;19:92-101.
29. Colvin L, Fallon M. Challenges in cancer pain management-bone pain. Eur J Cancer 2008;44:1083-90.
30. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL 3rd. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009;10:447-85.
31. Dahan A, Kest B, Waxman AR, Sarton E. Sex-specific responses to opiates: animal and human studies. Anesth Anal 2008;107:83-95.
32. Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010;8:23.
33. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996;392:189-93.
34. Büyükafşar K, Yalçin I, Kurt AH, Tiftik RN, Sahan-Firat S, Aksu F. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice. Eur J Pharmacol 2006;541:49-52.